Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges

This series of articles investigates a broad range of legal, management, ethical, economic, and social issues associated with the translation and commercialization of regenerative medicine technologies and services. Articles published in this series were invited from delegates that attended Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges, held In Toronto, ON, November 5-7, 2014. The organizers would like to thank the Stem Cell Network, the Cancer Stem Cell Consortium, Genome Canada, Genome Quebec, Genome Alberta, the Ontario Genomics Institute, the Canadian Institutes for Health Research, and Alberta Innovates-Health Solutions for their generous support of both this event.

All articles have been independently prepared by the authors and have been subject to the standard peer review processes of the journals.

  1. Content type: Research article

    The recent Canadian lawsuit on patent infringement, filed by the Children’s Hospital of Eastern Ontario (CHEO), has engendered a significant public debate on whether patenting genes should be legal in Canada. ...

    Authors: Li Du, Kalina Kamenova and Timothy Caulfield

    Citation: BMC Medical Ethics 2015 16:55

    Published on:

Advertisement